Investigation Overview
An investigation on behalf of current investors in Facet Biotech Corporation (Public, NASDAQ:FACT) concerning shareholder claims over possible breaches of fiduciary duty by the board of directors of Facet Biotech Corp. was announced. The investigation by la aw firm focuses on potential breaches of fiduciary duty and other violations of state law by the Board of Directors of Facet Bio...
You must register (for free) or login to view the entire investigation.